牛叉诊股

[{"date":"2026.07.30","stock":"-3.47","trade":"-1.97","ind":"-2.73"},{"date":"2026.07.29","stock":"-0.08","trade":"0.51","ind":"1.10"},{"date":"2026.07.28","stock":"-0.68","trade":"-1.30","ind":"-4.52"},{"date":"2026.07.27","stock":"3.68","trade":"3.35","ind":"2.72"},{"date":"2026.07.24","stock":"-2.87","trade":"-4.36","ind":"-2.47"},{"date":"2026.07.23","stock":"-2.71","trade":"0.60","ind":"0.44"},{"date":"2026.07.22","stock":"0.96","trade":"0.08","ind":"-1.42"},{"date":"2026.07.21","stock":"-1.60","trade":"-1.41","ind":"4.81"},{"date":"2026.07.20","stock":"2.63","trade":"-0.39","ind":"-0.71"},{"date":"2026.07.17","stock":"-13.16","trade":"-7.15","ind":"-5.40"},{"date":"2026.07.16","stock":"-0.76","trade":"0.97","ind":"-1.97"},{"date":"2026.07.15","stock":"6.09","trade":"3.85","ind":"-0.97"},{"date":"2026.07.14","stock":"-1.87","trade":"2.69","ind":"2.77"},{"date":"2026.07.13","stock":"1.50","trade":"-0.42","ind":"-3.48"},{"date":"2026.07.10","stock":"2.40","trade":"3.20","ind":"-2.29"},{"date":"2026.07.09","stock":"1.02","trade":"-0.42","ind":"3.07"},{"date":"2026.07.08","stock":"-3.87","trade":"-1.44","ind":"-1.87"},{"date":"2026.07.07","stock":"-7.26","trade":"-4.17","ind":"-1.24"},{"date":"2026.07.06","stock":"-0.39","trade":"0.97","ind":"-1.16"},{"date":"2026.07.03","stock":"1.24","trade":"1.73","ind":"0.64"},{"date":"2026.07.02","stock":"-6.01","trade":"1.10","ind":"-3.85"}]

广生堂,深证成指,化学制药指数

压力支撑

该股压力位为87.21元，支撑位为85.02元。

[{"text":"\u538b\u529b\u4f4d","value":"87.21","date":1785340800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"85.02","date":1785340800,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.3资金面打败了21%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：07月30日 20:30

机构今日流向(万元)	-1848.74	机构5日流向(万元)	-5258.34
机构10日流向(万元)	-9458.87	机构20日流向(万元)	-8745.91

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加282.55万股，其中基金净减仓4家，主力净增仓35家，请投资者中长期谨慎为宜。

截止2025-12-31，共66家主力机构（基金59家，基本养老保险基金1家，一般法人4家，QFII2家），持仓量总计5155.46万股，占流通A股37.71%
其中，基金持仓与2025-06-30相比：
增仓：5家，增持 3.58万股
减仓：9家，减持 272.58万股
新出现在主力名单中：47家，持有631.21万股
从主力名单中消失：12家，原持有130.94万股

消息面诊股

诊断结果：5.5消息面打败了33%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份解押	2026-07-30
一般消息	股东大会	年度股东大会	2026-04-29
一般消息	分红转增	不分配不转增	2026-04-29
重大利空	业绩预告	预计增亏	2026-01-31
一般消息	高管变动	取消监事会	2025-11-21
一般消息	分红转增	不分配不转增	2025-08-22

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	1条	0条

行业面诊股

诊断结果：1.9行业面打败了31%的股票化学制药行业最新资金流向

近10日来该行业走势总体向下，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，接近大盘。

[{"date":"2026.07.30","price":"-2.73","value":"-1.97"},{"date":"2026.07.29","price":"1.10","value":"0.51"},{"date":"2026.07.28","price":"-4.52","value":"-1.30"},{"date":"2026.07.27","price":"2.72","value":"3.35"},{"date":"2026.07.24","price":"-2.47","value":"-4.36"},{"date":"2026.07.23","price":"0.44","value":"0.60"},{"date":"2026.07.22","price":"-1.42","value":"0.08"},{"date":"2026.07.21","price":"4.81","value":"-1.41"},{"date":"2026.07.20","price":"-0.71","value":"-0.39"},{"date":"2026.07.17","price":"-5.40","value":"-7.15"},{"date":"2026.07.16","price":"-1.97","value":"0.97"},{"date":"2026.07.15","price":"-0.97","value":"3.85"},{"date":"2026.07.14","price":"2.77","value":"2.69"},{"date":"2026.07.13","price":"-3.48","value":"-0.42"},{"date":"2026.07.10","price":"-2.29","value":"3.20"},{"date":"2026.07.09","price":"3.07","value":"-0.42"},{"date":"2026.07.08","price":"-1.87","value":"-1.44"},{"date":"2026.07.07","price":"-1.24","value":"-4.17"},{"date":"2026.07.06","price":"-1.16","value":"0.97"},{"date":"2026.07.03","price":"0.64","value":"1.73"},{"date":"2026.07.02","price":"-3.85","value":"1.10"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	哈药股份	78.78%	-7.33%	6.7分
2	哈三联	19.05%	-4.46%	4.7分
3	迪哲医药	17.26%	-12.31%	4.4分
4	永安药业	15.60%	0.40%	5.2分
5	普洛药业	12.85%	-2.77%	5.6分
6	恩华药业	11.80%	1.38%	5.8分
7	海正药业	9.61%	-4.48%	5.6分
8	华海药业	9.46%	-2.51%	5.1分
9	健友股份	9.12%	3.43%	5.1分
10	罗欣药业	9.11%	-10.26%	5.5分
11	联环药业	8.62%	1.15%	5.1分
12	鲁抗医药	7.30%	-0.27%	5.2分
13	华北制药	7.10%	0.21%	5.6分
14	华邦健康	6.02%	1.85%	5.5分
15	赛分科技	5.94%	-14.56%	5.7分
16	天新药业	5.83%	-0.37%	4.8分
17	石药创新	4.38%	-6.76%	4.9分
18	九典制药	4.31%	2.16%	4.9分
19	ST人福	4.18%	2.63%	5.3分
20	国邦医药	3.95%	1.12%	4.8分
21	亿帆医药	3.86%	-0.10%	5.4分
22	德展健康	3.81%	-0.91%	4.3分
23	健康元	3.75%	-0.68%	5.6分
24	丽珠集团	3.47%	0.94%	5.8分
25	神奇制药	3.40%	0.00%	5.3分
26	浙江医药	3.33%	-0.98%	5.3分
27	川宁生物	3.22%	-0.12%	5.4分
28	福安药业	2.79%	-0.81%	5.3分
29	东北制药	2.47%	-2.98%	5.3分
30	百济神州	2.35%	-4.75%	5.0分
31	复星医药	2.34%	-0.64%	5.6分
32	卫信康	2.33%	1.50%	4.7分
33	恒瑞医药	2.17%	-0.47%	5.6分
34	华特达因	2.10%	1.22%	5.0分
35	ST天圣	2.09%	2.95%	5.0分
36	莎普爱思	2.01%	3.68%	4.7分
37	海普瑞	1.91%	-0.73%	5.1分
38	丰原药业	1.89%	0.00%	5.3分
39	仙琚制药	1.79%	1.67%	5.7分
40	金陵药业	1.64%	-0.16%	5.4分
41	华仁药业	1.53%	-1.12%	5.3分
42	-	1.38%	4.15%	分
43	亚虹医药	1.27%	-15.70%	4.1分
44	新天地	1.17%	-4.81%	4.7分
45	新和成	0.99%	-3.90%	5.1分
46	千红制药	0.89%	0.30%	5.7分
47	海翔药业	0.74%	6.05%	5.7分
48	辰欣药业	0.65%	-6.36%	4.1分
49	-	0.45%	4.18%	分
50	立方制药	0.19%	-2.59%	5.1分
51	ST南新	0.16%	-11.72%	3.6分
52	兴齐眼药	0.05%	4.52%	5.9分
53	华东医药	0.00%	-2.96%	5.6分
54	同和药业	0.00%	1.98%	5.2分
55	国药现代	-0.11%	1.73%	4.5分
56	东诚药业	-0.47%	1.75%	5.9分
57	益方生物	-0.84%	-15.20%	4.6分
58	华润双鹤	-0.86%	-2.99%	5.0分
59	ST惠程	-1.10%	3.75%	5.4分
60	-	-1.15%	3.77%	分
61	北大医药	-1.16%	-1.16%	4.9分
62	山河药辅	-1.39%	-0.50%	5.1分
63	福元医药	-1.39%	1.43%	4.8分
64	冀衡医药	-1.41%	2.94%	5.3分
65	海南海药	-1.49%	16.90%	4.3分
66	中哲精化	-2.04%	1.15%	5.3分
67	ST复华	-2.23%	2.63%	4.1分
68	常山药业	-2.31%	-12.14%	4.3分
69	拓新药业	-2.64%	-0.09%	4.6分
70	-	-2.73%	-0.52%	分
71	汉商集团	-2.74%	3.73%	4.9分
72	民生健康	-3.17%	-1.08%	4.9分
73	赛托生物	-3.20%	1.68%	4.5分
74	誉衡药业	-3.40%	-1.05%	5.5分
75	溢多利	-3.43%	0.90%	5.2分
76	博瑞医药	-3.57%	-14.23%	3.8分
77	-	-4.09%	1.48%	分
78	润都股份	-4.15%	-3.60%	5.1分
79	广济药业	-4.23%	2.26%	5.0分
80	ST能特	-4.24%	-5.04%	5.1分
81	金城医药	-4.31%	-0.55%	5.5分
82	科伦药业	-4.38%	-16.67%	5.5分
83	富士莱	-4.44%	1.54%	4.4分
84	力生制药	-4.53%	-0.70%	4.9分
85	奥锐特	-4.65%	0.84%	4.6分
86	莱美药业	-4.83%	-5.96%	4.6分
87	小方制药	-5.16%	-1.25%	4.4分
88	津药药业	-6.02%	-2.53%	4.7分
89	石药景峰	-6.24%	-7.72%	4.7分
90	诚意药业	-6.50%	-0.98%	4.2分
91	本立科技	-6.53%	0.29%	4.8分
92	北陆药业	-6.97%	-1.17%	5.0分
93	天宇股份	-7.10%	-2.45%	4.6分
94	京新药业	-7.23%	-3.89%	5.4分
95	复旦张江	-7.51%	-2.72%	4.5分
96	-	-8.23%	0.66%	分
97	泰恩康	-8.39%	-0.36%	5.1分
98	百利天恒	-8.49%	-7.47%	4.6分
99	微芯生物	-8.50%	-13.30%	4.6分
100	新华制药	-8.59%	0.07%	5.2分
101	康芝药业	-8.94%	0.33%	4.7分
102	信立泰	-9.03%	-5.18%	5.1分
103	吉贝尔	-9.07%	-1.21%	4.8分
104	通化金马	-9.41%	5.41%	5.4分
105	凯因科技	-9.57%	-1.59%	4.3分
106	海森药业	-9.67%	-0.80%	4.4分
107	中关村	-9.98%	-8.89%	4.9分
108	奥翔药业	-9.98%	-2.01%	4.1分
109	ST诺泰	-10.33%	-1.24%	4.5分
110	-	-10.56%	-14.48%	分
111	-	-10.91%	-2.12%	分
112	仟源医药	-11.19%	-0.92%	4.8分
113	盟科药业	-11.24%	-6.75%	4.6分
114	西点药业	-11.39%	-3.56%	4.7分
115	威尔药业	-11.44%	-2.47%	4.3分
116	艾力斯	-11.70%	-7.23%	5.5分
117	首药控股	-11.99%	-12.66%	4.3分
118	翰宇药业	-12.55%	-3.99%	5.0分
119	奥赛康	-12.68%	-2.30%	5.3分
120	舒泰神	-12.71%	-14.32%	4.5分
121	泽璟制药	-13.87%	-19.05%	4.7分
122	美诺华	-14.41%	-16.87%	4.0分
123	一品红	-14.57%	-4.59%	4.7分
124	悦康药业	-14.63%	-2.75%	4.4分
125	易明医药	-14.69%	-3.24%	5.5分
126	-	-14.75%	-33.89%	分
127	宣泰医药	-15.02%	-5.60%	4.6分
128	尔康制药	-15.07%	-2.98%	4.6分
129	金石亚药	-15.17%	-7.99%	4.8分
130	苑东生物	-15.34%	-15.50%	4.5分
131	东亚药业	-15.45%	2.44%	3.3分
132	海创药业	-15.78%	-11.34%	4.2分
133	海欣股份	-16.21%	-1.03%	4.4分
134	灵康药业	-16.83%	-4.73%	4.7分
135	贝达药业	-16.99%	-8.18%	4.8分
136	海辰药业	-17.63%	-4.35%	4.4分
137	亚太药业	-17.76%	-0.83%	4.4分
138	司太立	-18.69%	-0.94%	3.8分
139	纳微科技	-18.86%	-5.66%	5.1分
140	广生堂	-18.95%	-3.52%	4.2分
141	上海谊众	-19.07%	-9.52%	4.3分
142	华纳药厂	-19.41%	-13.94%	4.2分
143	昂利康	-19.44%	-7.58%	4.0分
144	双鹭药业	-19.58%	-3.76%	4.7分
145	亨迪药业	-19.94%	-9.27%	4.6分
146	向日葵	-20.87%	0.00%	3.7分
147	键凯科技	-20.95%	-18.44%	4.1分
148	汇宇制药	-21.65%	-7.41%	4.5分
149	海思科	-23.79%	-16.62%	5.4分
150	多瑞医药	-23.84%	-14.80%	3.9分
151	圣诺生物	-24.35%	-5.44%	4.6分
152	共同药业	-25.87%	-7.43%	5.0分
153	富祥股份	-27.88%	-7.12%	4.4分
154	宏源药业	-33.29%	-0.21%	4.3分
155	前沿生物	-37.07%	-18.98%	4.5分
156	必贝特	-38.43%	-41.25%	3.9分
157	花园生物	-42.54%	-2.70%	3.9分
158	科源制药	-46.53%	-13.85%	4.3分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.0基本面打败了18%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，但多数机构认为该股有长期投资价值。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 145/216 ， 38/216。

[{"date":"2026-03-31","value":"-9.80","vol":"0.45"},{"date":"2025-12-31","value":"-68.32","vol":"-1.85"},{"date":"2025-09-30","value":"-30.03","vol":"1.60"},{"date":"2025-06-30","value":"-20.43","vol":"1.26"},{"date":"2025-03-31","value":"-8.24","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-9.80	-68.32	-30.03	-20.43	-8.24
行业(%)	0.45	-1.85	1.60	1.26	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"66.95","vol":"50.98"},{"date":"2025-12-31","value":"62.32","vol":"49.96"},{"date":"2025-09-30","value":"61.91","vol":"49.79"},{"date":"2025-06-30","value":"61.09","vol":"49.69"},{"date":"2025-03-31","value":"65.63","vol":"49.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	66.95	62.32	61.91	61.09	65.63
行业(%)	50.98	49.96	49.79	49.69	49.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 71/216 ， 62/216。

[{"date":"2026-03-31","value":"0.85","vol":"24.44"},{"date":"2025-12-31","value":"-5.68","vol":"38.58"},{"date":"2025-09-30","value":"-3.21","vol":"142.64"},{"date":"2025-06-30","value":"-4.27","vol":"79.18"},{"date":"2025-03-31","value":"-18.69","vol":"0.16"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	0.85	-5.68	-3.21	-4.27	-18.69
行业(%)	24.44	38.58	142.64	79.18	0.16

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"9.00","vol":"52.58"},{"date":"2025-12-31","value":"-39.37","vol":"-24.51"},{"date":"2025-09-30","value":"-57.96","vol":"3.72"},{"date":"2025-06-30","value":"-85.05","vol":"66.32"},{"date":"2025-03-31","value":"-94.56","vol":"-9.37"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	9.00	-39.37	-57.96	-85.05	-94.56
行业(%)	52.58	-24.51	3.72	66.32	-9.37

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 109/216 ， 129/216。

[{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.29","vol":"0.41"},{"date":"2025-09-30","value":"0.21","vol":"0.31"},{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.07","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.07	0.29	0.21	0.15	0.07
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.26","vol":"0.64"},{"date":"2025-12-31","value":"1.31","vol":"2.56"},{"date":"2025-09-30","value":"0.93","vol":"1.94"},{"date":"2025-06-30","value":"0.62","vol":"1.30"},{"date":"2025-03-31","value":"0.28","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.26	1.31	0.93	0.62	0.28
行业(次)	0.64	2.56	1.94	1.30	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-20.41","vol":"-2.75"},{"date":"2025-12-31","value":"10.01","vol":"16.48"},{"date":"2025-09-30","value":"-24.06","vol":"4.59"},{"date":"2025-06-30","value":"-6.13","vol":"2.93"},{"date":"2025-03-31","value":"-12.86","vol":"-26.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-20.41	10.01	-24.06	-6.13	-12.86
行业	-2.75	16.48	4.59	2.93	-26.34

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.60","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.30","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.60	-	0.30	-
行业	0.00	1.60	0.00	1.72	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 71/216 ， 42/216。

[{"date":"2026-03-31","value":"1.02","vol":"3.58"},{"date":"2025-12-31","value":"1.08","vol":"3.33"},{"date":"2025-09-30","value":"1.03","vol":"3.50"},{"date":"2025-06-30","value":"0.67","vol":"3.68"},{"date":"2025-03-31","value":"0.69","vol":"3.58"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.02	1.08	1.03	0.67	0.69
行业	3.58	3.33	3.50	3.68	3.58

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.61","vol":"2.94"},{"date":"2025-12-31","value":"0.64","vol":"2.71"},{"date":"2025-09-30","value":"0.62","vol":"2.75"},{"date":"2025-06-30","value":"0.30","vol":"2.90"},{"date":"2025-03-31","value":"0.35","vol":"2.81"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.61	0.64	0.62	0.30	0.35
行业	2.94	2.71	2.75	2.90	2.81

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 92/216 ， 4/216。

[{"date":"2026-03-31","value":"77.64","vol":"33.40"},{"date":"2025-12-31","value":"75.27","vol":"34.57"},{"date":"2025-09-30","value":"69.18","vol":"34.00"},{"date":"2025-06-30","value":"76.15","vol":"34.11"},{"date":"2025-03-31","value":"73.45","vol":"34.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	77.64	75.27	69.18	76.15	73.45
行业(%)	33.40	34.57	34.00	34.11	34.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"4.36","vol":"9.83"},{"date":"2025-12-31","value":"3.80","vol":"1.77"},{"date":"2025-09-30","value":"2.74","vol":"1.19"},{"date":"2025-06-30","value":"3.55","vol":"0.88"},{"date":"2025-03-31","value":"3.06","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	4.36	3.80	2.74	3.55	3.06
行业(%)	9.83	1.77	1.19	0.88	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中邮证券	2026-05-20	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"-1.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.49","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-2.18","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-0.86","blueLineValue":"-0.54","type":"YC"}]

[广生堂]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]